Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Technical note: Inherent benchmark or not? Comparing Nash–Sutcliffe and Kling–Gupta efficiency scores
2019 Standout
ERA5-Land: a state-of-the-art global reanalysis dataset for land applications
2021 Standout
GloFAS-ERA5 operational global river discharge reanalysis 1979–present
2020
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials
2013 Standout
Maintenance of the Hematopoietic Stem Cell Pool by CXCL12-CXCR4 Chemokine Signaling in Bone Marrow Stromal Cell Niches
2006 Standout
Ischemia and reperfusion—from mechanism to translation
2011 Standout
The chemistry and biology of mucin-type O-linked glycosylation
2005 StandoutNobel
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial
2005
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
2010
Bleeding, Blood Transfusion, and Increased Mortality After Percutaneous Coronary Intervention
2009
Anemia, chronic renal disease and congestive heart failure—the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists
2006
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
Prevention of VTE in Nonsurgical Patients
2012 Standout
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
2002 Standout
Increased plasma viscosity as a reason for inappropriate erythropoietin formation.
1993 StandoutNobel
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors
2006
How Serious a Problem is Bleeding in Patients with Acute Coronary Syndromes?
2011
Cardiorenal Syndrome
2008 Standout
Calibration of the Global Flood Awareness System (GloFAS) using daily streamflow data
2018
Prevention of Venous Thromboembolism
2004 Standout
Risk factors and metabolic mechanisms in the pathogenesis of uraemic cardiac disease
2010
Myocardial Reperfusion Injury
2007 Standout
Prevention of Venous Thromboembolism
2008 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Chemotherapy-induced thrombosis
2006
A Single Bolus of a Long-acting Erythropoietin Analogue Darbepoetin Alfa in Patients with Acute Myocardial Infarction: A Randomized Feasibility and Safety Study
2006
Intravenous Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction
2011
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Renal innervation plays no role in oxygen-dependent control of erythropoietin mRNA levels
1992 StandoutNobel
Expansion of natural killer cells but not T cells in human interleukin 2/interleukin 2 receptor (Tac) transgenic mice.
1989 StandoutNobel
Renal erythropoietin: Properties and production
2006
Mobilizing Endothelial Progenitor Cells
2005
Proliferation Inhibition of Murine Pluripotent Haemopoietic Stem Cells By Interferon Or Poly I:C
1981
Activation and differentiation requirements of primary T cells in vitro.
1993 StandoutNobel
Regulation of Erythropoietin Production: New Insights Into Molecular Mechanisms of Oxygen Homeostasis
1994 StandoutNobel
Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes
2005
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Cytokine Signaling Through Nonreceptor Protein Tyrosine Kinases
1995 StandoutScience
On the pivotal role of PPARa in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury
2016 StandoutNobel
Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
1994 StandoutScience
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Polycythemia in transgenic mice expressing the human erythropoietin gene.
1989 StandoutNobel
Phorbol ester inhibits erythropoietin production in human hepatoma cells (Hep G2)
1992 StandoutNobel
Interleukin-2: Inception, Impact, and Implications
1988 StandoutScience
Works of Katie Smith being referenced
The interaction of erythropoietin with fetal liver cells. II. Inhibition of the erythropoietin effect by interferon.
1977
Benchmarking ensemble streamflow prediction skill in the UK
2018
Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation
2008
The cardiovascular effects of erythropoietin
2003
Uremic Cardiomyopathy and Insulin Resistance
2010
Cellular basis of uraemic cardiomyopathy: a role for erythropoietin?
2009
The ‘dirty dozen’ of freshwater science: detecting then reconciling hydrological data biases and errors
2017
The interaction of erythropoietin with fetal liver cells. I. Measurement of proliferation by tritiated thymidine incorporation.
1977